This symposium and video were funded by medac GmbH.
The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of medac GmbH or EMJ.
The speakers did not receive honoraria for the recording of this podcast.
This episode explores new insights into first-line conventional treatments for rheumatoid arthritis, including optimising methotrexate therapy, the benefits of subcutaneous administration, gut microbiota and treatment response, cardiovascular outcomes, interstitial lung disease, and the role of nurse-led patient education in improving patient care.
Moderator:
- Jessica Jinks1
Speakers:
- Gouri Koduri,2,3
- Arduino Mangoni,4,5
- Claire Daien,6
- Ricardo Ferreira7-10
1. Medical Writer and Moderator, EMJ, London, UK
2. Southend University Hospital, UK
3. Director of MSK Research, East of England, UK
4. Flinders University, Adelaide, Australia
5. Southern Adelaide Local Health Network, Australia
6. Centre Hospitalier Universitaire, Universitéde Montpellier, France
7. Nursing School of the University of Lisbon (ESEUL), Portugal
8. Rheumatology Department, ULS Coimbra, Portugal
9. QLV Research Consulting, Coimbra, Portugal
10. Advocacy Committee, EULAR, Kilchberg, Switzerland
